Herewith three items of pandemic news you may have missed recently: Cautionary lessons from Brazil’s second wave in Manaus; CureVac’s manufacturing partnership with Bayer; and long Covid’s entanglement with autoantibodies. Plus news briefs and a frippery. Autoantibodies and long Covid … Continue reading →
Herewith three items of pandemic news you may have missed recently: How wearable computers could predict Covid-19; the complicated situation with autoantibodies; and the late-stage trial of German company CureVac’s vaccine candidate. Plus the accustomed frippery. CureVac’s candidate enters Phase … Continue reading →
Herewith three items of pandemic news you may have missed recently: troubling details on Long Covid; news from the treatment front; and Minnesota’s Covid notification app. Plus the accustomed frippery. Minnesota’s Covid notification app Yesterday I downloaded and installed COVIDaware … Continue reading →
Herewith three important items of Covid-19 news you may have missed this week: mounting evidence for aerosol transmission, the persistence of symptoms in children, and growing awareness of the mental health toll of the pandemic. Plus a frippery. Aerosol transmission … Continue reading →
